THERMO FISHER SCIENTIFIC INC. 8-K

What Happened

• Thermo Fisher Scientific (TMO) announced its financial results for the fiscal quarter ended March 28, 2026 in a press release dated April 23, 2026.
• The press release is furnished as Exhibit 99.1 to the Form 8-K (with an Inline XBRL cover page, Exhibit 104). The Form 8-K states this furnished material is not “filed” under Section 18 of the Exchange Act and is not incorporated by reference except as expressly noted.

Key Details

• Announcement date: April 23, 2026.
• Reporting period: fiscal quarter ended March 28, 2026.
• Exhibit provided: Press Release (Exhibit 99.1) and Inline XBRL cover page (Exhibit 104).
• Form 8-K signed by Joseph R. Holmes, Vice President and Chief Accounting Officer.

Why It Matters

• The company’s quarterly results (earnings, revenue and other quarterly results) are material to investors and can affect TMO’s stock price and analyst expectations.
• The Form 8-K furnishes the press release for immediate disclosure; investors should review Exhibit 99.1 for the actual financial figures, guidance or management commentary, and monitor subsequent filings or calls for full context.
• Note the filer’s legal statement that the furnished press release is not considered “filed” under the Exchange Act, which affects how the information is treated for certain legal purposes.